Effect of Drug Use Stigma to Accessing Harm Reduction Services by People Who Inject Drugs in Nairobi County
DOI:
https://doi.org/10.47941/ijhs.3131Keywords:
Harm Reduction Services, PWID, Drug Use StigmaAbstract
Purpose: This study aims to explore the influence of drug use stigma on Harm Reduction Services (HRS) accessibility for People Who Inject Drugs (PWIDs) in Nairobi County. It seeks to understand the various barriers encountered by PWIDs, particularly those related to stigma, that prevent them from accessing essential services like syringe service programs.
Methodology: Adopting the Health Belief Model (HBM), this study utilized a cross-sectional research survey design. The target population was 1100 PWIDs in Starehe sub-county, as highlighted by the Kenya HIV/AIDS Indicator Survey of 2019. A sample size of 285 participants was determined using the Fischer sample determination formula, and participants were selected through the snowball technique.
Findings: A significant majority of respondents, 77.8% (n = 221), reported experiencing stigma due to their drug use, with most experiencing it monthly (34.9%) or weekly (28.2%), indicating a regular pattern. Mobile services were the most utilized HRS delivery model (30.3%, n=86), followed by peer outreach (28.2%, n=80). A considerable proportion (40.1%, n=114) reported moderate challenges in HRS accessibility. Stigma was identified as a pervasive barrier for PWIDs across all stages of drug use, originating from both social (family, friends, and community) and institutional (healthcare providers, law enforcement) domains.
Unique Contribution to Theory, Policy and Practice: This study shows that stigma significantly hinders PWIDs’ access to harm reduction services within the Health Belief Model. It calls for decriminalization, anti-discrimination laws, and expansion of OST and SCS. Practically, it urges participatory advocacy and inclusive outreach to reduce stigma and improve service accessibility for marginalized populations.
Downloads
References
Barry, C. L., McGinty, E. E., Pescosolido, B. A., & Goldman, H. H. (2014). Stigma, discrimination, treatment effectiveness, and policy: public views about drug addiction and mental illness. Psychiatric Services, 65(10), 1269-1272. https://doi.org/10.1176/appi.ps.201400140
Biancarelli, D. L., Biello, K. B., Childs, E., Drainoni, M., Salhaney, P., Edeza, A., & Bazzi, A. R. (2019). Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug and alcohol dependence, 19(8), 80-86. https://doi.org/10.1016/j.drugalcdep.2019.01.037
Camille S. (2014). The risk of being ‘too honest’: drug use, stigma and pregnancy. Health, Risk & Society, 16: (1), 36-50, DOI: 10.1080/ 13698575.2013.868408
Demaret, I., Quertemont, E., Litran, G., Magoga, C., Deblire, C., Dubois, N., ... & Ansseau, M. (2015). Efficacy of heroin-assisted treatment in Belgium: a randomized controlled trial. European Addiction Research, 21(4), 179-187. https://doi.org/10.1159/000369337
Dolan, K., & Millar, T. (2020). The effectiveness of needle and syringe programs in reducing the transmission of blood-borne viruses among people who inject drugs: A systematic review. Drug and Alcohol Review, 39(6), 696-706. https://doi.org/10.1111/dar.13011
Harm Reduction International (2021). Harm reduction financing in Kenya advocacy for local resource allocation.
Hedrich, D., Kerr, T., Dubois-Arber, F., & Mathers, B. (2010). Drug consumption facilities in Europe and beyond. In Harm Reduction: Evidence, Impacts, and Challenges (pp. 305-331). EMCDDA.
Kral, A. H., & Davidson, P. J. (2017). "Addressing the Nation's Opioid Epidemic: Lessons from an Unsanctioned Supervised Injection Site in the U.S." American Journal of Preventive Medicine, 53(6), 919-922. https://doi.org/10.1016/j.amepre.2017.06.010
Macias-Konstantopoulos, W., Heins, A., Sachs, C. J., Whiteman, P. J., Wingkun, N. J. G., & Riviello, R. J. (2021). Between emergency department visits: the role of harm reduction programs in mitigating the harms associated with injection drug use. Annals of emergency medicine, 77(5), 479-492. https://doi.org/10.1016/j.annemergmed.2020.11.008
Maina, G., et al. (2020). "Implementation and Outcomes of Methadone Maintenance Therapy in Kenya." BMC Health Services Research. 90(10) 239-255 https://doi.org/10.1186/s12913020-05267-w
Marshall, Z., Dechman, M. K., Minichiello, A., Alcock, L., & Harris, G. (2015). Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives. Drug and Alcohol Dependence, 15(1), 1-14. https://doi.org/10.1016/j.drugalcdep. 2015.03.002
Masese, L. N., Ludwig-Barron, N. T., Mbogo, L., Guthrie, B. L., Musyoki, H., Bukusi, D., & Monroe-Wise, A. (2022). Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya. Plos one, 17(12), 1-17. https://doi.org/10.1371/journal.pone.0278210
Mauro, P. M., Gutkind, S., Annunziato, E. M., & Samples, H. (2022). Use of medication for opioid use disorder among US adolescents and adults with need for opioid treatment, 2019. JAMA network open, 5(3), 1-14. doi:10.1001/jamanetworkopen.2022.3821
Mburu, G., et al. (2019). "Barriers to Harm Reduction Services for People Who Inject Drugs in Kenya." Harm Reduction Journal. 5(6) 890-898 https://doi.org/10.1186/s12954-019-03320
Meacham, M. C., O'Grady, K. E., DeMicco, D., & Johnson, J. D. (2019). Barriers to accessing opioid overdose prevention services among people who inject drugs. Journal of Substance Abuse Treatment, 10(10), 61-68. https://doi.org/10.1016/j.jsat.2019.02.006
Muncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). “They look at us like junkies”: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm reduction journal, 1(7), 1-9. https://doi.org/10.1186/s12954-02000399-8
Rhodes, T., & Scott, D. (2019). Stigma, criminalization, and barriers to harm reduction: Structural violence and harm reduction policy and practice. Substance Abuse Treatment, Prevention, and Policy, 14(1), 14-25. https://doi.org/10.1186/s13011-019-0179-x
Russell, C., Ali, F., Nafeh, F., LeBlanc, S., Imtiaz, S., Elton-Marshall, T., & Rehm, J. (2021). A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada. BMC Public Health, 21(1), 1-14. https://doi.org/10.1186/s12889-021-12104-w
Shirley-Beavan, S., Roig, A., Burke-Shyne, N., Pérez, A. B., & Prat, G. (2020). Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain. Harm Reduction Journal, 1(7), 78-90. https://doi.org/10.1186/s12954-020-00429-5
United Nations Office on Drugs and Crime (UNODC). (2022). World drug report 2022. Retrieved from https://www.unodc.org/unodc/en/data-and-analysis/wdr-2022.html
UNODC. World drug report 2016. 2016. https://www.unodc.org/doc/wdr201 6/WORLD_DRUG_REPORT_2016_web.pdf
Watson, T. M., Valleriani, J., & Hyshka, E. (2021). Canadian news media coverage of supervised consumption sites during a public health emergency: A content analysis. International Journal of Drug Policy, 8(7), 102987. https://doi.org/10.1016/j.drugpo. 2020.102987
WHO. (2019). Global status report on alcohol and health 2018. Geneva, Switzerland: World Health Organization. https://www.who.int/publications/i/item/global-status-report-onalcohol-and-health-2018
Wogen, J., & Restrepo, M. T. (2020). Human rights, stigma, and substance use. Health and Human Rights, 22(1), 51-60. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348456/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Evangeline Ndwiga Mukami, Mrs. Lillian Muiruri, Mr. Fredrick Kimemia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution (CC-BY) 4.0 License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
